Literature DB >> 23732895

The evidence for use of pneumococcal conjugate over polysaccharide in children.

Ray Borrow1.   

Abstract

Pneumococcal glycoconjugate vaccines are now used in infant immunization schedules, globally. Pneumococcal polysaccharide vaccines are still, however, advised from the second year of life to provide broader serotype coverage. The use of these polysaccharide vaccines has been under review, especially for children.

Entities:  

Keywords:  Pneumococcal; conjugate; polysaccharide; vaccine

Mesh：

Substances：

Year:  2013        PMID： 23732895      PMCID： PMC3901837          DOI： 10.4161/hv.24688

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  4 in total

1.  Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.

Authors:  Elizabeth Miller; Nicholas J Andrews; Pauline A Waight; Mary Pe Slack; Robert C George
Journal:  Lancet Infect Dis       Date:  2011-05-27       Impact factor: 25.071

Review 2.  Use of pneumococcal polysaccharide vaccine in children: what is the evidence?

Authors:  Ray Borrow; Paul T Heath; Claire-Anne Siegrist
Journal:  Curr Opin Infect Dis       Date:  2012-06       Impact factor: 4.915

3.  Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales.

Authors:  Nick Andrews; Pauline A Waight; Ray Borrow; Shamez Ladhani; Robert C George; Mary P E Slack; Elizabeth Miller
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

4.  Pneumococcal conjugate vaccines and otitis media: an appraisal of the clinical trials.

Authors:  Mark A Fletcher; Bernard Fritzell
Journal:  Int J Otolaryngol       Date:  2012-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.